Trials / Completed
CompletedNCT00631150
A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Patients in community-based practices correspond to the 25% of patients who need a first add-on drug when not controlled by their standard monotherapy drug. This was a therapeutic use trial in which the population corresponds more closely to that seen in daily clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam (Keppra) |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2004-07-01
- Completion
- 2004-07-01
- First posted
- 2008-03-07
- Last updated
- 2013-11-15
Source: ClinicalTrials.gov record NCT00631150. Inclusion in this directory is not an endorsement.